Upside, Downside Movers in the A.M.
Upside:
-REPL +75% (confirms resubmits RP1 BLA for advanced melanoma in combination with nivolumab)
-DELL +33% (earnings, guidance)
-PD +23% (earnings, guidance)
-ASTC +21% (momentum)
-NTAP +18% (earnings, guidance)
-QURE +17% (higher in sympathy with REPL)
-BRUN +15% (enters 36-mo GPU server rental deal with Thinking Machines Lab)
-SOFI +13% (momentum)
-HPE +11% (higher in sympathy with DELL)
-OKTA +9.3% (earnings, guidance)
-SMCI +9.0% (higher in sympathy with DELL)
-GCO +7.3% (earnings, guidance)
-TEM +6.6% (FDA approves tumor-only label expansion for Tempus xT CDx)
-HPQ +5.1% (higher in sympathy with DELL)
-IFF +3.1% (confirms to sell Food Ingredients business to CVC Capital Partners for ~$4.3B)
-MDB +3.0% (earnings, guidance)
Downside:
-GAP -15% (earnings, guidance)
-S -15% (earnings, guidance)
-AEO -12% (earnings, guidance)
-ASTS -12% (lower in sympathy with Blue Origin)
-IHRT -12% (reportedly early-stage talks over a potential sale of iHeartMedia to SiriusXM, which would create an audio giant, have stalled after the two sides were unable to come to terms)
-ESTC -8.4% (earnings, guidance)
-ADSK -6.7% (earnings, guidance)
-KRMN -6.5% (prices upsized 14M shares at $61.00/shr in secondary offering by holders)
-RDW -6.4% (profit taking)
-IOVA -6.3% (lower following REPL news)
-AMBA -4.0% (earnings, guidance)
-AGIO -3.8% (will not advance tebapivat in LR-MDS; Phase 2b trial misses predefined transfusion-independence threshold)
-PATH -2.8% (earnings, guidance)
Positions: none.
